BGLC

BioNexus Gene Lab Corp.

BGLC · CIK 1737523 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$10M
20192024
Net Income−$2M
20192024
Operating CF−$2M
20192024
Free Cash Flow−$2M
20192024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B
Gross Profit$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
R&D Expense$0.0B—————
SG&A Expense——————
Operating Income$-0.0B$-0.0B$-0.0B$0.0B$0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$0.0B$0.0B$-0.0B
EPS (Basic)——————
EPS (Diluted)$-0.09—————

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Total Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents—$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕
Operating Cash Flow$-0.0B$-0.0B$0.0B$0.0B$0.0B$-0.0B
Investing Cash Flow$0.0B$-0.0B$-0.0B$-0.0B$0.0B$-0.0B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B
Financing Cash Flow$0.0B$0.0B$0.0B$-0.0B$-0.0B$-0.0B
← Companies